Viewing data from:

OXYBUTYNIN CHLORIDE

ANDA

OXYBUTYNIN CHLORIDE | A204010 | AMNEAL PHARMACEUTICALS

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$0.0875

per ea

Lowest NADAC/Unit

$0.0875

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00904657004OXYBUTYNIN CL ER 5 MG TABLET	$0.0875	EA	Generic	—	2026-06-17
00904657006OXYBUTYNIN CL ER 5 MG TABLET	$0.0875	EA	Generic	—	2026-06-17
00904657061OXYBUTYNIN CL ER 5 MG TABLET	$0.0875	EA	Generic	—	2026-06-17
65162037110OXYBUTYNIN CL ER 5 MG TABLET	$0.0875	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$70.61

Highest Price

$124.04

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00904-6570-06OXYBUTYNIN ER 5MG	$70.61	FSS	The Harvard Drug Group L.L.C. dba Major Pharmaceuticals and Rugby Labs	05/31/2030
00904-6570-61OXYBUTYNIN ER 5MG	$124.04	FSS	The Harvard Drug Group L.L.C. dba Major Pharmaceuticals and Rugby Labs	05/31/2030

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain6 active DMFs4 inactive

6 active API suppliers hold Drug Master Files for this ingredient.

PCASOXYBUTYNIN CHLORIDE USP

DMF 64121986

APITORIA PHARMA PRIVATE LTDOXYBUTYNIN CHLORIDE

DMF 194472006

HARMAN FINOCHEM LTDOXYBUTYNIN CHLORIDE

DMF 228522009

RESONANCE LABORATORIES PVT LTDOXYBUTYNIN CHLORIDE (OBTN)

DMF 237572010

TAPI NL BVOXYBUTYNIN CHLORIDE USP

DMF 265372012

THINQ PHARMA-CRO LTDOXYBUTYNIN CHLORIDE USP

DMF 343362020

ZEELAND CHEMICALS INCInactiveOXYBUTYNIN CHLORIDE

DMF 62721986

ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIVInactiveOXYBUTYNIN CHLORIDE

DMF 63691986

SANOFI AVENTIS SPAInactiveOXYBUTYNIN CHLORIDE

DMF 128401998

WOCKHARDT BIO AGInactiveOXYBUTYNIN CHLORIDE USP

DMF 160612002

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 5MG

0 patents0 exclusivities▴

TABLET, EXTENDED RELEASE;ORAL | Approved: Nov 23, 2015

No patent or exclusivity listings for this strength.

#002 — 10MG

0 patents0 exclusivities▾

TABLET, EXTENDED RELEASE;ORAL | Approved: Nov 23, 2015

#003 — 15MG

0 patents0 exclusivities▾

TABLET, EXTENDED RELEASE;ORAL | Approved: Nov 23, 2015